Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masse

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Journal Francais D'Ophtalmologie|January 1, 1995
[Organ culture preservation of the human cornea at +31 degrees C and risk of infection]M Erbezci, P H Monnot, Y Michel-Briand, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1978
Application of cell electrophoretic methods (preparative and analytical) in demonstrating the surface heterogeneity of T-lymphocytes in manP Chollet, P Hervé, J Chassagne, et al.
Transplantation Proceedings|November 18, 2009
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodiumJ-F Bilodeau, P Montambault, J-L Wolff, et al.
La Nouvelle Presse Medicale|March 6, 1976
[Letter: Heterogeneity of T-lymphocytes in man. Value of the simultaneous use of methods of preparative and analytical electrophoresis]P Hervé, M Masse, A Peters, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 28, 1998
[Surveillance of biocontamination of the environment of labile blood products: its role in a quality assurance program]P Morel, C Naegelen, M Masse, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Soluble Fas is a marker of coronary artery disease in patients with end-stage renal diseaseM J Hébert, M Masse, N Vigneault, et al.
Vox Sanguinis|January 4, 2008
Quality of leucoreduced red blood cell concentrates: 5 years of follow-up in FranceA Chabanel, F Carrat, S Begue, et al.
Transfusion|July 1, 1992
Validation of a simple method to count very low white cell concentrations in filtered red cells or plateletsM Masse, C Naegelen, N Pellegrini, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 7, 2016
A Method for Creating Artificial Thrombi In Vitro Using a Rotating Mechanical SurfaceStaci L Jessen, Andrew M Masse, Mallory D Carpenter, et al.
Gene Therapy|August 1, 1995
Mesothelial cell-mediated gene therapy: feasibility of an ex vivo strategyJ A Nagy, T R Shockley, E M Masse, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal Francais D'Ophtalmologie|January 1, 1995
[Organ culture preservation of the human cornea at +31 degrees C and risk of infection]M Erbezci, P H Monnot, Y Michel-Briand, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|May 1, 1978
Application of cell electrophoretic methods (preparative and analytical) in demonstrating the surface heterogeneity of T-lymphocytes in manP Chollet, P Hervé, J Chassagne, et al.
Transplantation Proceedings|November 18, 2009
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodiumJ-F Bilodeau, P Montambault, J-L Wolff, et al.
La Nouvelle Presse Medicale|March 6, 1976
[Letter: Heterogeneity of T-lymphocytes in man. Value of the simultaneous use of methods of preparative and analytical electrophoresis]P Hervé, M Masse, A Peters, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 28, 1998
[Surveillance of biocontamination of the environment of labile blood products: its role in a quality assurance program]P Morel, C Naegelen, M Masse, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Soluble Fas is a marker of coronary artery disease in patients with end-stage renal diseaseM J Hébert, M Masse, N Vigneault, et al.
Vox Sanguinis|January 4, 2008
Quality of leucoreduced red blood cell concentrates: 5 years of follow-up in FranceA Chabanel, F Carrat, S Begue, et al.
Transfusion|July 1, 1992
Validation of a simple method to count very low white cell concentrations in filtered red cells or plateletsM Masse, C Naegelen, N Pellegrini, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 7, 2016
A Method for Creating Artificial Thrombi In Vitro Using a Rotating Mechanical SurfaceStaci L Jessen, Andrew M Masse, Mallory D Carpenter, et al.
Gene Therapy|August 1, 1995
Mesothelial cell-mediated gene therapy: feasibility of an ex vivo strategyJ A Nagy, T R Shockley, E M Masse, et al.
Pageof 8